[HTML][HTML] Tracking SARS-CoV-2 lineage B. 1.1. 7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data …
…, M Costa, L Carneiro, P Casaca, P Pinto-Leite… - …, 2021 - eurosurveillance.org
We show that the SARS-CoV-2 B.1.1.7 lineage is highly disseminated in Portugal, with the
odds of B.1.1.7 proportion increasing at an estimated 89% (95% confidence interval: 83–95%…
odds of B.1.1.7 proportion increasing at an estimated 89% (95% confidence interval: 83–95%…
mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in …
…, A Peralta-Santos, J Lima, P Pinto Leite… - …, 2021 - eurosurveillance.org
Through deterministic data linkage of health registries, mRNA vaccine effectiveness (VE)
against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older adults…
against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older adults…
[HTML][HTML] Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022
…, S Ribeiro, JV Martins, P Casaca, PP Leite… - …, 2022 - eurosurveillance.org
Up to 27 May 2022, Portugal has detected 96 confirmed cases of monkeypox. We describe
27 confirmed cases (median age: 33 years (range: 22–51); all males), with an earliest …
27 confirmed cases (median age: 33 years (range: 22–51); all males), with an earliest …
Omicron (BA. 1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B. 1.617. 2)
…, V Moutinho, A Leite, I Kislaya, AP Rodrigues, PP Leite… - MedRxiv, 2022 - medrxiv.org
Introduction Early reports showed that Omicron (BA.1) SARS-CoV-2 could be less severe.
However, the magnitude of risk reduction of hospitalization and mortality of Omicron (BA.1) …
However, the magnitude of risk reduction of hospitalization and mortality of Omicron (BA.1) …
[HTML][HTML] Stability of hybrid versus vaccine immunity against BA. 5 infection over 8 months
…, RM Ribeiro, E Fernandes, PP Leite… - The Lancet Infectious …, 2023 - thelancet.com
(A) Incidence of documented SARS-CoV-2 infection overlaid with the period of dominance
of the BA. 1 and BA. 2 variants, Jan 1–Apr 14, 2022, divided into 15-day sub-intervals (shades …
of the BA. 1 and BA. 2 variants, Jan 1–Apr 14, 2022, divided into 15-day sub-intervals (shades …
[HTML][HTML] COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA. 5 circulation: cohort study based …
…, AP Rodrigues, R Franco, PP Leite… - …, 2022 - eurosurveillance.org
We measured vaccine effectiveness (VE) against COVID-19-related severe outcomes in
elderly people in Portugal between May and July 2022. In ≥ 80 year-olds, the second booster …
elderly people in Portugal between May and July 2022. In ≥ 80 year-olds, the second booster …
CT evaluation of appendicitis and its complications: imaging techniques and key diagnostic findings
N Pinto Leite, JM Pereira, R Cunha… - American Journal of …, 2005 - Am Roentgen Ray Soc
OBJECTIVE. This article reviews various CT protocols for appendicitis, identifies key CT
findings for diagnosing appendicitis, discusses unusual manifestations such as chronic and …
findings for diagnosing appendicitis, discusses unusual manifestations such as chronic and …
SARS-CoV-2 BA. 5 vaccine breakthrough risk and severity compared with BA. 2: a case-case and cohort study using Electronic Health Records in Portugal
Background In a context of multiple Omicron lineages circulation, it is relevant to clarify the
effect of vaccination and previous infections on the risk of infection and severe post-infection …
effect of vaccination and previous infections on the risk of infection and severe post-infection …
[HTML][HTML] Comparative effectiveness of COVID-19 vaccines in preventing infections and disease progression from SARS-CoV-2 omicron BA. 5 and BA. 2, Portugal
We estimated comparative primary and booster vaccine effectiveness (VE) of SARS-CoV-2
Omicron BA. 5 and BA. 2 lineages against infection and disease progression. During April–…
Omicron BA. 5 and BA. 2 lineages against infection and disease progression. During April–…
[HTML][HTML] COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged≥ 65 …
…, AP Rodrigues, D Sequeira, J Lima, C Cruz, PP Leite… - PLoS …, 2022 - journals.plos.org
Background Using data from electronic health registries, this study intended to estimate the
COVID-19 vaccine effectiveness (VE) in the population aged 65 years and more, against …
COVID-19 vaccine effectiveness (VE) in the population aged 65 years and more, against …